Acquisition of resistance to antitumor alkylating agent ACNU: a possible target of positron emission tomography monitoring

This publication has 20 references indexed in Scilit:

• Imaging Drug Resistance with Radiolabeled Molecules
  Current Pharmaceutical Design, 2004
• Randomized Controlled Trial on Malignant Brain Tumors-Activities of the Japan Clinical Oncology Group-Brain Tumor Study Group-
  Neurologia medico-chirurgica, 2004
• PET scan in the therapeutic strategy
  The Hematology Journal, 2004
• Imaging proliferation in vivo with [F-18]FLT and positron emission tomography
  Nature Medicine, 1998
• Quantification of O 6 -methylguanine-DNA methyltransferase mRNA in human brain tumors
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1996
• The Antitumor Effect of MX2, a New Morpholino Anthracycline, against Malignant Glioma Cell Lines and Its Subcellular Distribution
  Neurosurgery, 1995
• Establishment of ACNU-resistant Rat Gliosarcoma Cell Lines and Their Characteristics
  Neurologia medico-chirurgica, 1991
• Repair of O6-ethylguanine in DNA protects rat 208F cells from tumorigenic conversion by N-ethyl-N-nitrosourea.
  Proceedings of the National Academy of Sciences, 1990
• Linkage between O6-methylguanine-DNA methyltransferase (O6-MT) activity and cellular resistance to antitumour nitrosoureas in cultured rat brain tumour cell strains
  Acta Neurochirurgica, 1990
• Adaptive response to alkylating agents involves alteration in situ of O6-methylguanine residues in DNA
  Nature, 1979